FDA Inspection
Sagent PharmaceuticalsSagent Pharmaceuticals – FDA Inspection, May 11, 2012
Record Details
This FDA Inspection record concerns Sagent Pharmaceuticals, with an inspection on May 11, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Sagent Pharmaceuticals
- Inspection Date
- May 11, 2012
- Product Type
- Drugs
View Company Profile
ID · cf99e690-6aba-4034-85aa-0a8d5711bd0a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 782558
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 314.80(c)(2)Failure to report non-alert ADEs
- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sagent Pharmaceuticals
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 20, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 18, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 24, 2018 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| August 19, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 11, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sagent Pharmaceuticals
- FDA Inspection 1231342 - 2024-09-20
- FDA Inspection 1114257 - 2019-12-18
- FDA Inspection 1066792 - 2018-09-24
- FDA Inspection 940865 - 2015-08-19
- FDA Inspection 717757 - 2011-03-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.